Back
Corcept Therapeutics 10K Form
Buy
55
CORT
Corcept Therapeutics
Last Price:
$56.46
Seasonality Move:
9.53%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2024-05-01 | 10Q | CORT/Corcept Therapeutics Quarterly |
2023-11-01 | 10Q | CORT/Corcept Therapeutics Quarterly |
2023-08-02 | 10Q | CORT/Corcept Therapeutics Quarterly |
2023-05-03 | 10Q | CORT/Corcept Therapeutics Quarterly |
2022-11-03 | 10Q | CORT/Corcept Therapeutics Quarterly |
2022-08-04 | 10Q | CORT/Corcept Therapeutics Quarterly |
Receive CORT News And Ratings
See the #1 stock for the next 7 days that we like better than CORT
CORT Financial Statistics
Sales & Book Value
Annual Sales: | $675M |
---|---|
Cash Flow: | $59.2M |
Price / Cash Flow: | 32.1 |
Annual Sales: | $6.47 |
Price / Book: | 8.6 |
Profitability
EPS (TTM): | 1.24000 |
---|---|
Net Income (TTM): | $141.2M |
Gross Margin: | $664.2M |
Return on Equity: | 23.78% |
Return on Assets: | 19.52% |
Corcept Therapeutics Earnings Forecast
Key Corcept Therapeutics Financial Ratios
-
The Gross Profit Margin over the past 20 years for CORT is 98.39%.
-
The Selling, General & Administrative Expenses for CORT have been equal to 41.53% of Gross Profit Margin.
-
The Research & Development expenses have been 36.57% of Revenue.
-
The Interest Expense is 0.04% of Operating Income.
-
The Net Earning history of CORT is 20.92% of Total Revenues.
-
Per Share Earnings over the last 24 years have been positive in 13 years.
Corcept Therapeutics Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NASDAQ |
---|---|
Industry: | Pharmaceuticals |
Sector: | Health Care |
Current Symbol: | CORT |
CUSIP: | 218352 |
Website: | corcept.com |
Debt
Debt-to-Equity Ratio: | 0 |
---|---|
Current Ratio: | 3.35 |
Quick Ratio: | 3.11 |
Price-to-Earnings
Trailing P/E Ratio: | 45.04 |
---|---|
Forward P/E Ratio: | 15.64 |
CORT Technical Analysis vs Fundamental Analysis
Buy
55
Corcept Therapeutics (CORT)
is a Buy
Is Corcept Therapeutics a Buy or a Sell?
-
Corcept Therapeutics stock is rated a BuyThe current Corcept Therapeutics [CORT] share price is $55.40. The Score for CORT is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.